Paul Jansen, Board Member & Senior Advisor with Haselmeier and retired from Sanofi as Associate Vice President, Medical Device Development, is a Professional Engineer with more than 30 years of experience in medical devices development. He completed his engineering degree in mechanical engineering and has completed graduate work in biomedical engineering at the University of Toronto.
Mr. Jansen has extensive experience in the design, development, manufacturing and lifecycle management of medical devices. Mr. Jansen has multiple patents to his name and has deep experience in the creation and management of intellectual property portfolios. He has successfully led teams that have developed and launched several award-winning devices, including Lantus SoloStar the world’s most popular insulin pen injection device. In addition, he has expertise in the design and development of injection moulding systems and electronic components.
Mr. Jansen is an active member of the International Standards Organisation and is currently co vice-chair of TC84. He often convenes working groups within TC84 and is currently leading WG 15 Change Management of Devices Intended for Administration of Medicinal Products.